Order Article Reprints

Williet N, Petrillo A, Roth G, Ghidini M, Petrova M, Forestier J, Lopez A, Thoor A, Weislinger L, De Vita F, et al. Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study. Cancers. 2021; 13(11):2797. https://doi.org/10.3390/cancers13112797

Williet, Nicolas, Angelica Petrillo, Gaël Roth, Michele Ghidini, Mila Petrova, Julien Forestier, Anthony Lopez, Audrey Thoor, Lucie Weislinger, Ferdinando De Vita, and et al. 2021. "Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study" Cancers 13, no. 11: 2797. https://doi.org/10.3390/cancers13112797

Williet, N., Petrillo, A., Roth, G., Ghidini, M., Petrova, M., Forestier, J., Lopez, A., Thoor, A., Weislinger, L., De Vita, F., Taieb, J., & Phelip, J. M. (2021). Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study. Cancers, 13(11), 2797. https://doi.org/10.3390/cancers13112797